| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/30/2007 | US20070202103 Compounds For Targeting |
| 08/30/2007 | US20070202100 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 08/30/2007 | US20070202096 XAF genes and polypeptides: methods and reagents for modulating apoptosis |
| 08/30/2007 | US20070202094 TIMP3 as VEGF inhibitor |
| 08/30/2007 | US20070202089 Insecticidal protein which enhance insect resistance in plants; biological pest control; |
| 08/30/2007 | US20070202048 Comprises gadodiamide, bone graft matrix, and osteoinductive factor comprising BMP-2 at concentration of 0.1-1.5 mg/ml, wherein concentration of gadodiamide is greater than concentration of BMP-2 in bone graft composition and bone graft composition induces bone formation; iodine-free |
| 08/30/2007 | DE60215502T2 Verfahren zur Selektion einer Transkription-Modulatierenden DNA-Sequenz unter Verwendung einem Vektor mit einem Transkriptions-Repressions-Aktivem Element A method for selecting a transcription-Modulatierenden DNA sequence using a vector with a transcriptional repression active element |
| 08/30/2007 | DE60122300T2 Hepatitis b kernprotein fusionsproteine Hepatitis B core protein fusion proteins |
| 08/30/2007 | DE19627193B4 Rekombinantes myxomatisches Virus Recombinant virus myxomatisches |
| 08/30/2007 | CA2651793A1 Hiv fusion inhibitor peptides with improved biological properties |
| 08/30/2007 | CA2643408A1 Novel lipases and uses thereof |
| 08/30/2007 | CA2643226A1 Antibodies against human il-22 and uses therefor |
| 08/30/2007 | CA2642910A1 Coagulation factor x polypeptides with modified activation properties |
| 08/30/2007 | CA2642451A1 Shiga toxoid chimeric proteins |
| 08/30/2007 | CA2641909A1 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 08/30/2007 | CA2641908A1 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
| 08/30/2007 | CA2638867A1 Peptides that block the binding of igg to fcrn |
| 08/30/2007 | CA2638866A1 Peptide based inhibition of capcna protein-protein interactions in cancer |
| 08/30/2007 | CA2638838A1 Ammonia transporter gene and use thereof |
| 08/30/2007 | CA2638835A1 Gene encoding acetolactate synthase and use thereof |
| 08/30/2007 | CA2638828A1 Immunomodulatory and anti-tumor peptides derived from lalf |
| 08/30/2007 | CA2638827A1 Protection of the retina against laser injury by adnf peptides such as nap and sal |
| 08/30/2007 | CA2638803A1 Modulation of bone formation |
| 08/30/2007 | CA2638775A1 Peptide vaccine for inducing production of anti-amyloid-.beta.-peptide antibody |
| 08/30/2007 | CA2638762A1 Ammonia transporter gene and use thereof |
| 08/30/2007 | CA2635472A1 Soluble receptors and methods for treating autoimmune or demyelinating diseases |
| 08/30/2007 | CA2628253A1 Therapeutic anti-her2 antibody fusion polypeptides |
| 08/30/2007 | CA2604276A1 Gene encoding protein with vicinal diketone or diacetyl-reducing activity and use thereof |
| 08/30/2007 | CA2604068A1 Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 08/29/2007 | EP1826570A1 Reagent containing oxygen isotope-labeled hemoglobin for examining vital tissue and method of producing the same |
| 08/29/2007 | EP1826268A1 Ccr6- deficient mice or cells and modulation of inflammatory diseases |
| 08/29/2007 | EP1826264A1 Primate model for orthopox virus infections |
| 08/29/2007 | EP1826218A1 Antihuman baff antibody |
| 08/29/2007 | EP1826217A1 Method for identification of antigenic peptides |
| 08/29/2007 | EP1826216A1 Glp-1 derivatives |
| 08/29/2007 | EP1826215A2 Method of obtaining the expression or improving the rate of expression of a gene |
| 08/29/2007 | EP1825863A1 Recombinant porcine adenovirus vector |
| 08/29/2007 | EP1825258A1 Assays for superantigens |
| 08/29/2007 | EP1824988A2 Site-directed modification of fviii |
| 08/29/2007 | EP1824979A2 Methods, products and uses involving platelets and/or the vasculature |
| 08/29/2007 | EP1824978A1 Hcv f protein and uses thereof |
| 08/29/2007 | EP1824883A2 Saquinavir derivatives useful in immunoassay |
| 08/29/2007 | EP1824882A1 Osteoprotegerin variant proteins |
| 08/29/2007 | EP1824881A1 Tgr3-like protein receptor |
| 08/29/2007 | EP1824880A1 Soluble hla-e molecules and their use for diagnosing and treating pathologies |
| 08/29/2007 | EP1824879A2 HYBRID PROTEINS WITH ErbB4 EXTRACELLULAR DOMAIN AND NEUREGULIN HEPARIN-BINDING DOMAIN FOR TARGETING |
| 08/29/2007 | EP1824878A1 Tnf antagonists |
| 08/29/2007 | EP1824877A1 Nucleic acids corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 08/29/2007 | EP1824876A2 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 08/29/2007 | EP1824875A1 Plant proteins having an abscisic acid binding site and methods of use |
| 08/29/2007 | EP1824517A2 Methods of treatment using melanopsin |
| 08/29/2007 | EP1824514A2 Toll like receptor 3 antagonists, methods and uses |
| 08/29/2007 | EP1824512A2 Improved dna immunization with recombinase/transposase |
| 08/29/2007 | EP1824511A2 Adjuvant activity of gastrointestinal peptides |
| 08/29/2007 | EP1824505A1 Method for determining inflammatory processes, and pharmaceutical compositions for the treatment thereof |
| 08/29/2007 | EP1824501A1 Protein hydrolysate with antidiabetic effect |
| 08/29/2007 | EP1670903B1 Treatment of neurodegenerative diseases |
| 08/29/2007 | EP1594469B1 Peptidic nanoparticles as drug delivery and antigen display systems |
| 08/29/2007 | EP1578382A4 Botulinum neurotoxin b receptors and use thereof |
| 08/29/2007 | EP1572952A4 Novel polynucleotide and polypeptide sequences and uses thereof |
| 08/29/2007 | EP1517913B9 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins |
| 08/29/2007 | EP1511376A4 Transgenic zebrafish models for thrombosis |
| 08/29/2007 | EP1463816B1 Method for controlled induction of somatic mutations and use thereof in proteomics |
| 08/29/2007 | EP1409529B1 Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
| 08/29/2007 | EP1394543B1 Screening method |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | EP1280889B1 Compositions and methods for producing antigen-presenting cells |
| 08/29/2007 | EP1165781B1 Protease resistant flint analogs |
| 08/29/2007 | EP1163844B1 Transgenic mollusc and method for constructing the same |
| 08/29/2007 | EP1140997B1 Chlamydia trachomatis antigens |
| 08/29/2007 | EP1054963B1 Sequences of an ih ionic channel and the use thereof |
| 08/29/2007 | EP1047301B1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 08/29/2007 | EP1024814B1 Use of antifungal agents for the topical treatment of fungus-induced mucositis |
| 08/29/2007 | EP1009814B1 Human receptor tyrosine kinase, kdr |
| 08/29/2007 | EP1007653B1 Detection methods comprising the use of polypeptides comprising a coiled-coil and an addition site |
| 08/29/2007 | EP1007568B1 Collagen mimics |
| 08/29/2007 | EP0998585B1 Screening methods using an atpase protein from a virus of the flaviviridae family |
| 08/29/2007 | EP0975755B9 Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor |
| 08/29/2007 | EP0953644B1 Systems for the mass production of proteins or peptides by microorganisms of the genus humicola |
| 08/29/2007 | EP0942930B1 Purification of neurotrophins |
| 08/29/2007 | EP0935657B1 Modified steroid hormone receptors |
| 08/29/2007 | EP0910635B1 Hematopoietic cytokine receptor |
| 08/29/2007 | EP0763059B1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
| 08/29/2007 | EP0736605B2 Process for producing proteins |
| 08/29/2007 | CN101027412A Urine markers for detection of bladder cancer |
| 08/29/2007 | CN101027397A Nucleotide sequences and polypeptides encoded thereby useful for modifying nitrogen use efficiency characteristics in plants |
| 08/29/2007 | CN101027396A Cry1F and Cry1Ac transgenic cotton lines and event-specific identification thereof |
| 08/29/2007 | CN101027394A Modified oncolytic viruses |
| 08/29/2007 | CN101027389A Method for producing L-arginine, L-ornithine or L-citrulline |
| 08/29/2007 | CN101027321A 孕酮受体结构 Progesterone receptor structure |
| 08/29/2007 | CN101027320A FGFR binding peptides |
| 08/29/2007 | CN101027319A 肝素结合肽 Heparin-binding peptides |
| 08/29/2007 | CN101027318A Insulin-oligomer conjugates, formulations and uses thereof |
| 08/29/2007 | CN101027317A HPV vaccine comprising peptides from host cell proteins |
| 08/29/2007 | CN101027079A 嵌合蛋白 Chimeric protein |
| 08/29/2007 | CN101027073A Natriuretic compounds, conjugates, and uses thereof |
| 08/29/2007 | CN101027047A Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 08/29/2007 | CN101025419A Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
| 08/29/2007 | CN101024845A 方法 Method |
| 08/29/2007 | CN101024842A Expression vectors encoding epitopes of target-associated antigens and its design method |